Selective modulation of PPARγ signaling as a new therapeutic strategy for Alzheimer's disease

2022/45/N/NZ7/01418

Keywords

Descriptors

  • NZ3_005: Neurobiologia molekularna
  • NZ7_012: Prewencja chorób człowieka
  • NZ7_014: Farmacja, farmakoterapia, farmakologia

Panel

NZ7 – Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology

Host institution

Instytut Farmakologii PAN

Voivodeship: małopolskie

Other projects carried out by the institution »

Principal investigator (from the host institution)

Karolina Barbara Przepiórska-Drońska

Number of co-investigators in the project: 3

Call

PRELUDIUM 21 – announced on 2022-03-28

Amount awarded
210 000 PLN
Project start date
2023-02-02
Project end date
2027-02-01
Project duration
48 months (the same as in the proposal)
Project status
Pending project

Project description

Download the project description in a pdf file

Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.

« New search

Graphic design and implementation: Jakub Piotrowski